| Primary |
|
| Completed Suicide |
33.3% |
| Pruritus |
33.3% |
| Respiratory Arrest |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
64.2% |
| Anxiety |
5.2% |
| Drug Use For Unknown Indication |
5.2% |
| Hypertension |
4.7% |
| Overdose |
4.7% |
| Depression |
4.2% |
| Irritability |
1.9% |
| Metastases To Lung |
1.9% |
| Renal Cell Carcinoma |
1.9% |
| Bipolar Disorder |
0.9% |
| Neuropathy Peripheral |
0.9% |
| Attention Deficit/hyperactivity Disorder |
0.5% |
| Cataplexy |
0.5% |
| Fibromyalgia |
0.5% |
| Hallucination, Auditory |
0.5% |
| Hypothyroidism |
0.5% |
| Menopausal Symptoms |
0.5% |
| Multiple Allergies |
0.5% |
| Narcolepsy |
0.5% |
| Obsessive-compulsive Disorder |
0.5% |
|
| Completed Suicide |
35.8% |
| Toxicity To Various Agents |
9.4% |
| Overdose |
5.7% |
| Respiratory Arrest |
5.7% |
| Sinus Tachycardia |
5.7% |
| Drug Hypersensitivity |
3.8% |
| Poisoning |
3.8% |
| Sedation |
3.8% |
| Thyroid Function Test Abnormal |
3.8% |
| Vascular Calcification |
3.8% |
| Brain Injury |
1.9% |
| Cardio-respiratory Arrest |
1.9% |
| Disturbance In Attention |
1.9% |
| Exposure Via Ingestion |
1.9% |
| Hypokalaemia |
1.9% |
| Intentional Overdose |
1.9% |
| Myalgia |
1.9% |
| Peritoneal Haemorrhage |
1.9% |
| Somnambulism |
1.9% |
| Somnolence |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.5% |
| Depression |
18.1% |
| Cataplexy |
5.6% |
| Hypertension |
5.6% |
| Anxiety |
5.1% |
| Breast Cancer |
4.6% |
| Metastatic Malignant Melanoma |
4.6% |
| Type 2 Diabetes Mellitus |
4.6% |
| Cardiac Disorder |
3.7% |
| Smoking Cessation Therapy |
3.7% |
| Bipolar Disorder |
2.8% |
| Bone Disorder |
2.8% |
| Fibromyalgia |
2.8% |
| Major Depression |
2.8% |
| Prostate Cancer Metastatic |
2.8% |
| Pulmonary Arterial Hypertension |
2.8% |
| Somnolence |
2.8% |
| Blood Cholesterol Increased |
2.3% |
| Diabetes Mellitus |
2.3% |
| Atrial Fibrillation |
1.9% |
|
| Weight Decreased |
13.6% |
| Nausea |
9.1% |
| Tonsil Cancer |
7.6% |
| Weight Increased |
7.6% |
| Serotonin Syndrome |
6.1% |
| Vomiting |
6.1% |
| Depression |
4.5% |
| Dyspnoea |
4.5% |
| Off Label Use |
4.5% |
| Schizophrenia |
4.5% |
| Stress |
4.5% |
| Clostridial Infection |
3.0% |
| Completed Suicide |
3.0% |
| Injection Site Swelling |
3.0% |
| Muscle Contractions Involuntary |
3.0% |
| Parasomnia |
3.0% |
| Pneumonia |
3.0% |
| Sleep Disorder |
3.0% |
| Suicide Attempt |
3.0% |
| Syncope |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Antiplatelet Therapy |
30.0% |
| Depression |
20.0% |
|
| Drug Interaction |
33.3% |
| Haematoma |
33.3% |
| Spontaneous Haematoma |
33.3% |
|
